Eric Zudak

WORK HISTORY

EDUCATION

SKILLS

ABOUT ERIC ZUDAK

Thalocan is focused on clinical outcome measures, from development and validation of the instruments themselves to standardized training for existing endpoint assessments as well as sourcing expertise and disease state images to support clinical trial instruction. It is an incredibly exciting time in Immuno-dermatology, and the opportunity to contribute to better outcomes for patients is great motivation. I am very fortunate for the opportunities I have had and I try to approach my job with a sense of gratitude. I have learned a great deal from a number of extremely talented and passionate people, on a variety of subjects, both procedural as well as professional. The challenges and obstacles have also offered a great education. All of these lessons can be boiled down into one simple idea: If you are always acting in the best interests of you client, you can\'t be wrong. During the past 19 years, I have had the opportunity to work closely with the application development team and contribute to new product development. Trifecta\'s service offerings have been improved and expanded dramatically over the last year. The most rewarding part of this process is having a positive effect on the day to day experience of our clients in their jobs, making life easier for Study teams on DAY ONE of the contract. I have seen first hand how Trifecta solutions can have a dramatic effect on the work-life balance of Study and Trial Managers. Specialties: Clinical outcome assessments for Immuno-dermatology endpoints, Sales and Business Development, SaaS and PaaS consulting.